Unusual primary intracranial dural-based poorly differentiated synovial sarcoma with t(X; 18)(p11; q11)

Neuropathology

Volumn 33, Issue 1, 2013, Pages 75-82

  Lin, Yu Jing ^a   Yang, Qing xu ^b   Tian, Xiao ying ^c   Li, Bin ^a   Li, Zhi ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b HUIZHOU MUNICIPAL CENTRAL HOSPITAL   (China)

^c HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

Chromosomal translocation; Differential diagnosis; Dural neoplasm; Round cell tumor; Synovial sarcoma

Indexed keywords

ADULT; ANTERIOR CRANIAL FOSSA; ARTICLE; BLURRED VISION; CANCER RADIOTHERAPY; CASE REPORT; CELL STRUCTURE; CHROMOSOME ANALYSIS; CYTOPLASM; DURA MATER; HUMAN; IMMUNOHISTOCHEMISTRY; INTRACRANIAL TUMOR; MALE; NEUROIMAGING; POLYP; POORLY DIFFERENTIATED SYNOVIAL SARCOMA; PRIORITY JOURNAL; SYNOVIAL SARCOMA; TUMOR CELL;

BRAIN NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 18; CHROMOSOMES, HUMAN, X; DURA MATER; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; SARCOMA, SYNOVIAL; TRANSLOCATION, GENETIC; YOUNG ADULT;

EID: 84873275855     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2012.01320.x     Document Type: Article

References (24)

1. Fisher C, de Bruijn DRH, Geurts van Kessel A. Synovial sarcoma. In: Fletcher CDM, Unni KK, Mertens F, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon: IARC press, 2007; 200-204.
2. Butori C, Hofman V, Attias R, Mouroux J, Pedeutour F, Hofman P. Diagnosis of primary esophageal synovial sarcoma by demonstration of t(X;18) translocation: a case report. Virchows Arch 2006; 449: 262-267.
3. Ryu CH, Cho KJ, Choi SH. Synovial sarcoma of the thyroid gland. Clin Exp Otorhinolaryngol 2011; 4: 204-206.
4. Coen M, Gagliano T, Tsolaki E, Marchetti G, Marchetti E, Mascoli F. Primary intravascular synovial sarcoma of the femoral vein in a male patient, case report. Eur J Vasc Endovasc Surg 2008; 36: 224-226.
5. Vera J, García MD, Marigil M, Abascal M, Lopez JI, Ligorred L. Biphasic synovial sarcoma of the abdominal wall. Virchows Arch 2006; 449: 367-372.
6. Pan CC, Chang YH. Primary synovial sarcoma of the prostate. Histopathology 2006; 48: 321-323.
7. Kleinschmidt-DeMasters BK, Mierau GW, Sze CI etal. Unusual dural and skull-based mesenchymal neoplasms: a report of four cases. Hum Pathol 1998; 29: 240-245.
8. Horbinski C, Cieply K, Bejjani GK, McFadden K. Primary intracranial dural-based synovial sarcoma with an unusual SYT fluorescence in situ hybridization pattern. J Neurosurg 2008; 109: 897-903.
9. Kransdorf MJ. Malignant soft-tissue tumors in a large referral population: distribution of diagnoses by age, sex, and location. AJr. Am J Roentgenol 1995; 164: 129-134.
10. Yokouchi Y, Hiruta N, Oharaseki T etal. Primary cardiac synovial sarcoma: a case report and literature review. Pathol Int 2011; 61: 150-155.
11. Chatzipantelis P, Kafiri G. Retroperitoneal synovial sarcoma: a clinicopathological study of 6 cases. J BUON 2008; 13: 211-216.
12. Weiss SW, Goldblum JR. Synovial sarcoma. In: Weiss SW, Goldblum JR, eds. Enzinger and Weiss's Soft Tissue Tumors. St. Louis, MO: Mosby, 2001; 1483-1509.
13. Perry A, Louis DN, Scheithauer BW. Meningiomas. In: Loui DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. WHO Classification of Tumors of the Central Nervous System, 4th edn. Lyon: IARC Press, 2007; 164-172.
14. Aldape KD, Plate KH, Vortmeyer AO, Zagzag D, Neumann HPH. Haemangioblastoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. WHO Classification of Tumours of the Central Nervous System, 4th edn. Lyon: IARC press, 2007; 184-186.
15. Folpe AL, Schmidt RA, Chapman D, Gown AM. Poorly differentiated synovial sarcoma: immunohistochemical distinction from primitive neuroectodermal tumors and high-grade malignant peripheral nerve sheath tumors. Am J Surg Pathol 1998; 22: 673-682.
16. Smith TA, Machen SK, Fisher C, Goldblum JR. Usefulness of cytokeratin subsets for distinguishing monophasic synovial sarcoma from malignant peripheral nerve sheath tumor. Am J Clin Pathol 1999; 112: 641-648.
17. Foo WC, Cruise MW, Wick MR, Hornick JL. Immunohistochemical staining for TLE1 distinguishes synovial sarcoma from histologic mimics. Am J Clin Pathol 2011; 135: 839-844.
18. Lino-Silva LS, Flores-Gutiérrez JP, Vilches-Cisneros N, Domínguez-Malagón HR. TLE1 is expressed in the majority of primary pleuropulmonary synovial sarcomas. Virchows Arch 2011; 459: 615-621.
19. Rajaram V, Brat DJ, Perry A. Anaplastic meningioma versus meningeal hemangiopericytoma: immunohistochemical and genetic markers. Hum Pathol 2004; 35: 1413-1438.
20. Unni KK, Inwards CY, Bridge JA, Kindblom LF, Wold LE. AFIP Atlas of Tumor Pathology 4th Series Fascicle 2: Tumors of the Bones and Joints. Washington, DC: American Registry of Pathology, 2005; 99-104.
21. Lin L, Varikatt W, Dexter M, Ng T. Diagnostic pitfall in the diagnosis of mesenchymal chondrosarcoma arising in the central nervous system. Neuropathology 2012; 32: 82-90.
22. Wang L, Motoi T, Khanin R etal. Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data. Genes Chromosomes Cancer 2012; 51: 127-139.
23. Spillane AJ, A'Hern R, Judson IR, Fisher C, Thomas JM. Synovial sarcoma: a clinicopathologic, staging, and prognostic assessment. J Clin Oncol 2000; 18: 3794-3803.
24. van de Rijn M, Barr FG, Xiong QB, Salhany KE, Fraker DL, Fisher C. Radiation-associated synovial sarcoma. Hum Pathol 1997; 28: 1325-1328.